ASCO 2024: Brenus Pharma Presented “BreAK-CRC” First-in-human (FIH) Phase I/IIA Trial of STC-1010: a Next-generation Cancer Vaccine Targeting mCRC
Brenus Pharma, French biotech developing its proprietary discovery platform: “Stimulated-Tumor-Cell” (STC), has presented the study design of “BreAK-CRC” First-in-human of STC-1010, Brenus’ lead candidate, during ASCO annual meeting (31st May – 4th June 2024) - Trials in Progress poster session, in Chicago.
Poster here. | Benoit You et al. Journal of Clinical Oncology42, TPS3635-TPS3635(2024). DOI:10.1200/JCO.2024.42.16_suppl.TPS3635
Authors information’s: here.
Based on STC-1010’ robust preclinical package in vivo, in ovo, ex vivo, BreAK-CRC study will be launched in 9 oncology early phase centers (EU, US) with expert investigators in immunotherapy:
“Cancer vaccines continue to show promising clinical results in solid tumors. STC-1010, is a new immunotherapeutic approach based on cancer vaccine mechanism of action for colorectal cancer patients. In that, “BreAK-CRC” Study is eagerly expected. CRC is still challenging as current immunotherapies were found only active in dMMR/MSI-H “hot” CRC. For the pMMR/MSS population, representing 95% of patients with CRC, there is an important medical need for drugs likely to heat up “cold” tumors and have a real impact for the patient.” François Ghiringhelli (M.D,PhD) Director of early clinical unit CLIPP2 and BreAK-CRC study coordinator, Centre Georges-François Leclerc, University of Burgundy, Dijon, France.
BreAK-CRC trial protocol has been reviewed in pre-submission meeting with the French National Health Authority. The submission of the CTA through the clinical trial information system of the European union is ongoing.
The Phase I/IIA clinical trial, aims to evaluate the safety and efficacy of STC-1010 in patients with unresectable advanced or metastatic colorectal cancer, 2nd cause of cancer mortality worldwide.
The Phase I will assess the tolerability of two dose levels of STC-1010, combined with low-dose immunostimulants and standard of care chemotherapy (SoC). The Phase IIA will enroll patients to further evaluate the treatment's efficacy, particularly focusing on 12-month non-progression rate.
Exploratory analysis will evaluate the immune response and the ctDNA dynamic.
About Brenus Pharma:
Brenus Pharma developing a pioneering discovery platform, Stimulated-Tumor-Cell (STC), leading the way of a new generation of active immunotherapies against cancer.
STC Platform mimics patients' relapsing conditions in vitro to educate the patient’s immune system against tumor evolution and mechanisms of relapse. The STCs will educate the immune system to 200+ specific targets of interest, validated by multi-omics analysis and patient biopsies databases.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240613547215/en/
Contacts
BRUN Marion
contact@brenus-pharma.com | Follow us on LinkedIn -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.c
om%2Fcompany%2Fbrenus-pharma%2F%3FviewAsMember%3Dtrue&esheet=54055695&newsitemid
=20240613547215&lan=en-US&anchor=LinkedIn&index=11&md5=c9d6c036859296d901cb3c03c
f8cb633 | Website -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbrenus-pharma.
com%2F&esheet=54055695&newsitemid=20240613547215&lan=en-US&anchor=Website&index=
12&md5=79f932aeac9dbfc5b848d23213ac44aa
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VSPO, the Largest Esports Company in Asia, Announces New CEO and International Brand Alignment to Hero Esports13.10.2024 10:44:00 CEST | Press Release
China-based esports tournament organizer VSPO announced that it has appointed a new CEO and has engaged in an “international brand alignment,” renaming itself to “Hero Esports.” Danny Tang, co-founder and current CFO, will become the company’s new CEO, with the mission of expanding the company’s “operations and driving international growth.” Dino Ying, Founder and CEO of VSPO, will transition to Executive Chairman, to focus on exploring and creating the next generation of esports products and experiences. Additionally, dedicating more time to the Esports Asian Champions League (ACL), and to support the development of the Esports World Cup and the Olympic Esports Games. About VSPO (soon to be Hero Esports) Founded in 2016, VSPO is the biggest esports company in Asia, producing more than 7,000 matches every year that captivate an online fan base of over 800 million. With a global presence encompassing 14 office locations and eight top-tier esports arenas, VSPO offers a comprehensive suit
HONGQI EH7 and EHS7 Deliver Amazing Performance in the Media Test Drive13.10.2024 07:19:00 CEST | Press Release
On October 11th, HONGQI held a new vehicle test drive event for European media in Paris, France, inviting more than ten mainstream automotive media representatives, including Agence France Presse, Le Journal de L'Auto, Auto Bild, and Motor1, to experience the excellent style of EH7 and EHS7. At the event, Mr. Liu Hongtao, the General Manager of HONGQI Overseas, introduced the HONGQI brand and the new vehicles, EH7 and EHS7. Meanwhile, Mr. Giles Taylor, the Vice President of Global Design and Chief Creative Officer of FAW Group, presented the aesthetic design of the vehicles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241012601143/en/ HONGQI EH7 and EHS7 Deliver Amazing Performance in the Media Test Drive (Photo: Business Wire) Several media representatives were impressed by the driving experience of the EH7 and EHS7. Equipped with an electric drive system featuring a maximum power of 455kW and a torque of 756Nm, the two
Oakio Concludes Successful Participation at Batimat Paris 202411.10.2024 22:51:00 CEST | Press Release
Oakio has successfully concluded its participation in Batimat 2024, held in Paris from September 30th to October 3rd. The event provided a valuable platform to showcase a range of innovative Wood-Plastic Composite (WPC) solutions, while also facilitating connections with industry professionals from across the globe. Highlighting Innovation and Sustainability At Batimat, Oakio presented its latest range of sustainable building materials, including decking, cladding, fencing, beam, and pergolas. These WPC products are crafted from a blend of recycled oak wood fibers and high-density polyethylene, offering superior durability, weather resistance, and low maintenance. The Elashield decking, recognized for its advanced slip resistance, attracted attention for its use in poolside and high-traffic areas. The Armstrong WPC pergola and Proshield WPC beam, with their enhanced protection against moisture, UV rays, and staining, also drew significant interest for their aesthetic appeal and long-la
SIAL Innovation Awards Prize Winners 202411.10.2024 17:27:00 CEST | Press Release
SIAL Innovation is a global food innovation observatory, run in partnership with ProtéinesXTC, that reviews thousands of applications submitted by the show’s exhibitors every two years. Through SIAL Innovation, SIAL Paris recognises these innovations through about twenty theme-based awards allocated by category (dairy, seafood, frozen food, etc.), as well as special awards like the Own the Change (CSR) Awards, the Start-up Awards, and the Public’s Choice Awards for which the SIAL Paris ecosystem is invited to vote before and during the show. This 2024 edition features new special prizes such as the Top 3 Countries Awards, for the pick of the nations that have offered the most innovative products, and the Africa Awards. SIAL Paris is a trendsetter and offers visitors a unique insight into the future of global food through a dedicated area at the show featuring products from the SIAL Innovation selection. INNOVATION BOOSTED IN 2024 Quality and quantity: the SIAL Innovation 2024 Awards sh
Datos Insights Recognizes Laserfiche Customer Stonehage Fleming with 2024 Impact Award for Technology Transformation11.10.2024 16:00:00 CEST | Press Release
Laserfiche — the leading SaaS provider of intelligent content management and business process automation — today announced that its customer, Stonehage Fleming, has won the Datos Insights 2024 Digital Wealth Management Impact Award for Technology Transformation. This award recognizes Stonehage Fleming’s innovation in leveraging Laserfiche’s suite of content management, process automation, integration, information governance and intelligent data capture tools to drive operational excellence across the organization. Stonehage Fleming, a leading international provider of wealth management and fiduciary services, addressed a number of challenges with its transformation, including inefficient legacy systems, increasing regulatory complexity, and meeting evolving client needs. To achieve its digital initiatives, the IT team adopted Laserfiche as a process orchestration engine across its 19 global offices. The team automated various legacy processes in the Business Development department whic
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom